BENZTROPINE tablet

Maa: Yhdysvallat

Kieli: englanti

Lähde: NLM (National Library of Medicine)

Aktiivinen ainesosa:

BENZTROPINE MESYLATE (UNII: WMJ8TL7510) (BENZTROPINE - UNII:1NHL2J4X8K)

Saatavilla:

Contract Pharmacy Services-PA

INN (Kansainvälinen yleisnimi):

BENZTROPINE MESYLATE

Koostumus:

BENZTROPINE MESYLATE 1 mg

Antoreitti:

ORAL

Prescription tyyppi:

PRESCRIPTION DRUG

Valtuutuksen tilan:

Abbreviated New Drug Application

Valmisteyhteenveto

BENZTROPINE- BENZTROPINE TABLET
CONTRACT PHARMACY SERVICES-PA
----------
BENZTROPINE 1MG 207
BENZTROPINE MESYLATE Tablets USP0.5 mg, 1 mg and 2 mg Leading Pharma,
LLC Leading
Pharma, LLC BENZTROPINE MESYLATE BENZTROPINE MESYLATE BENZTROPINE
MESYLATE BENZTROPINE ANHYDROUS DIBASIC CALCIUM PHOSPHATE LACTOSE
MONOHYDRATE STARCH, CORN CELLULOSE, MICROCRYSTALLINE ANHYDROUS
LACTOSE TALC CORN OIL EP;136 BENZTROPINE MESYLATE BENZTROPINE MESYLATE
BENZTROPINE MESYLATE BENZTROPINE ANHYDROUS DIBASIC CALCIUM PHOSPHATE
LACTOSE MONOHYDRATE STARCH, CORN CELLULOSE, MICROCRYSTALLINE
ANHYDROUS LACTOSE TALC CORN OIL EP;137 BENZTROPINE MESYLATE
BENZTROPINE
MESYLATE BENZTROPINE MESYLATE BENZTROPINE ANHYDROUS DIBASIC CALCIUM
PHOSPHATE LACTOSE MONOHYDRATE STARCH, CORN CELLULOSE,
MICROCRYSTALLINE ANHYDROUS LACTOSE TALC CORN OIL EP;138 DESCRIPTION
Benztropine mesylate, USP is a synthetic compound containing
structural features found in atropine and
diphenhydramine. It is designated chemically as 3α-(Diphenylmethoxy)
-1α-H,5 α H-tropane
methanesulfonate. Its molecular formula is C21H25NO•CH4O3S, and its
structural formula is:
Benztropine mesylate, USP is a crystalline white powder, very soluble
in water, and has a molecular
weight of 403.54. Each benztropine mesylate tablet, USP for oral
administration contains benztropine
mesylate 0.5 mg, 1 mg or 2 mg. Inactive ingredients: corn starch,
dicalcium phosphate anhydrous,
hydrogenated vegetable oil, lactose anhydrous, lactose monohydrate,
microcrystalline cellulose, talc.
Chemical structure CLINICAL PHARMACOLOGY Benztropine mesylate
possesses both
anticholinergic and antihistaminic effects, although only the former
have been established as
therapeutically significant in the management of parkinsonism. In the
isolated guinea pig ileum, the
anticholinergic activity of this drug is about equal to that of
atropine; however, when administered
orally to unanesthetized cats, it is only about half as active as
atropine. In laboratory animals, its
antihistaminic activity and duration of action appro